Back
Results - Announcements
Sales rise 69.50% to Rs 5.39 crore
Shukra Pharmaceuticals standalone net profit rises 110.20% in the June 2025 quarter
13-Aug-2025, 05:11
Net profit of Shukra Pharmaceuticals rose 110.20% to Rs 1.03 crore in the quarter ended June 2025 as against Rs 0.49 crore during the previous quarter ended June 2024. Sales rose 69.50% to Rs 5.39 crore in the quarter ended June 2025 as against Rs 3.18 crore during the previous quarter ended June 2024.
Net profit of Shukra Pharmaceuticals rose 110.20% to Rs 1.03 crore in the quarter ended June 2025 as against Rs 0.49 crore during the previous quarter ended June 2024. Sales rose 69.50% to Rs 5.39 crore in the quarter ended June 2025 as against Rs 3.18 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 5.39 | 3.18 | 69 |
| OPM % | 24.68 | 25.79 | - |
| PBDT | 2.17 | 1.48 | 47 |
| PBT | 1.38 | 0.81 | 70 |
| NP | 1.03 | 0.49 | 110 |
Powered by Capital Market - Live News